Increased Levels of Soluble CD14 in Sera of Periodontitis Patients

AUTOR(ES)

Hayashi, Joichiro

FONTE

American Society for Microbiology

RESUMO

Soluble CD14 (sCD14) mediates the response to lipopolysaccharide (LPS) in cells lacking membrane-bound CD14. We determined sCD14 concentrations in the sera of 38 periodontitis patients and 25 healthy controls by enzyme-linked immunosorbent assay. The sCD14 levels in the sera of patients with periodontitis were significantly higher than those of healthy subjects and decreased after treatment. Enhanced levels of sCD14 in serum may contribute to the host response to LPS in periodontitis. Furthermore, we showed in vitro that addition of LPS enhanced the release of sCD14 by monoblastic U937 cells treated with 1α,25-dihydroxyvitamin D3. Thus, increased sCD14 levels in periodontitis patients may be due to chronic exposure to LPS.

Documentos Relacionados

• Elevated Levels of Lipopolysaccharide-Binding Protein and Soluble CD14 in Plasma in Neonatal Early-Onset Sepsis
• Soluble CD14 Activates Monocytic Cells Independently of Lipopolysaccharide
• CD14 Is Expressed and Released as Soluble CD14 by Human Intestinal Epithelial Cells In Vitro: Lipopolysaccharide Activation of Epithelial Cells Revisited
• CD14 Is Expressed and Released as Soluble CD14 by Human Intestinal Epithelial Cells Cells In Vitro: Lipopolysaccharide Activation of Epithelial Cells Revisted
• Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.